Chang, H., Peng, L., Tao, Y., Chen, C., Xiao, W., Hu, Y., & Gao, Y. (2019). Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy. Cancer Med.

Chang, Hui, Liang Peng, Ya‐Lan Tao, Chen Chen, Wei‐Wei Xiao, Yong‐Hong Hu, and Yuan‐Hong Gao. "Necessity of Concurrent Chemotherapy in N2‐3 Nasopharyngeal Carcinoma Treated With Neoadjuvant Chemotherapy of ≥3 Cycles Followed By Intensity‐modulated Radiotherapy." Cancer Med 2019.

Chang, Hui, et al. "Necessity of Concurrent Chemotherapy in N2‐3 Nasopharyngeal Carcinoma Treated With Neoadjuvant Chemotherapy of ≥3 Cycles Followed By Intensity‐modulated Radiotherapy." Cancer Med 2019.